Familiarity, confidence and preference of artificial intelligence feedback and prompts by Australian breast cancer screening readers

Author:

Trieu Phuong Dung (Yun)ORCID,Barron Melissa L.ORCID,Jiang ZhengqiangORCID,Tavakoli Taba SeyedamirORCID,Gandomkar ZibaORCID,Lewis Sarah J.ORCID

Abstract

Objectives This study explored the familiarity, perceptions and confidence of Australian radiology clinicians involved in reading screening mammograms, regarding artificial intelligence (AI) applications in breast cancer detection. Methods Sixty-five radiologists, breast physicians and radiology trainees participated in an online survey that consisted of 23 multiple choice questions asking about their experience and familiarity with AI products. Furthermore, the survey asked about their confidence in using AI outputs and their preference for AI modes applied in a breast screening context. Participants’ responses to questions were compared using Pearson’s χ2 test. Bonferroni-adjusted significance tests were used for pairwise comparisons. Results Fifty-five percent of respondents had experience with AI in their workplaces, with automatic density measurement powered by machine learning being the most familiar AI product (69.4%). The top AI outputs with the highest ranks of perceived confidence were ‘Displaying suspicious areas on mammograms with the percentage of cancer possibility’ (67.8%) and ‘Automatic mammogram classification (normal, benign, cancer, uncertain)’ (64.6%). Radiology and breast physicians preferred using AI as second-reader mode (75.4% saying ‘somewhat happy’ to ‘extremely happy’) over triage (47.7%), pre-screening and first-reader modes (both with 26.2%) (P < 0.001). Conclusion The majority of screen readers expressed increased confidence in utilising AI for highlighting suspicious areas on mammograms and for automatically classifying mammograms. They considered AI as an optimal second-reader mode being the most ideal use in a screening program. The findings provide valuable insights into the familiarities and expectations of radiologists and breast clinicians for the AI products that can enhance the effectiveness of the breast cancer screening programs, benefitting both healthcare professionals and patients alike.

Funder

This study is funded by National Breast Cancer Foundation (Australia)

Cancer Institute NSW Early Career Fellowship 2022

Publisher

CSIRO Publishing

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3